glycolic, retinoic, etc.) are often added as second line therapy
Tirzepatide (Mounjaro, Zepbound) is a once-weekly subcutaneous injection approved by the FDA for type 2 diabetes management and chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Seek medical attention if irritation persists
Not for human or veterinary use 126 in stock BPC-157 Current Batch: 11013-004 Test Date: May 25th, 2026 Purity: 99.55% Net Content: 12.15 mg BPC-157 Product Description BPC-157 is a synthetic peptide fragment commonly cited in cellular and molecular pathway research
As a part of our weight loss program, these injections boost energy, combat fatigue and contribute to your overall well being

Benefits (Research Focus) Studied as a Khavinson-class tetrapeptide bioregulator for epigenetic gene-expression modulation Investigated for telomerase activity and telomere length in cell-culture models Explored for pineal gland regulation and melatonin / serotonin biosynthesis Examined for circadian rhythm research and sleep-wake cycle endpoints in aged models Researched for geroprotective effects and age-associated gene expression patterns What Researchers Look At Telomerase enzymatic activity and telomere length in human somatic cell cultures Pineal gland melatonin synthesis enzymes (AANAT, ASMT) and circulating melatonin AACG-motif binding affinity and promoter region transcriptional modulation Antioxidant defense markers (SOD, catalase, glutathione peroxidase) in aged tissues Comparative bioregulator pharmacology versus other Khavinson peptides (Pinealon, Cortagen, Vesugen) Quick Specs Form: Gelatin capsule Strength: 3 mg / capsule Quantity: 30 capsules per bottle Excipient: Microcrystalline cellulose (MCC) pharmaceutical-grade filler Purity: 99% Storage: Store in a cool, dry, dark place Identity Basics Compound: Epithalon Synonyms: Epitalon
